Skip to main content
Clinical Trials/DRKS00007885
DRKS00007885
Completed
未知

Safety and efficacy of preoperative sphincter botulinum toxin injection on postoperative pancreatic fistula after distal pancreatectomy

niversitätsklinikum Heidelberg0 sites29 target enrollmentStarted: March 9, 2015Last updated:

Overview

Phase
未知
Status
Completed
Sponsor
niversitätsklinikum Heidelberg
Enrollment
29

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
N/a: Single Arm Study
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • Patients scheduled for elective distal pancreaectomy for various underlying diseases • Age equal or greater than 18 years • Written informed consent

Exclusion Criteria

  • Creatinine clearance \< 30 mL/min (estimated by Cockcroft\-Gault) • Serious cardiovascular disease (e.g. myocardial infarction in the last 12 months, congestive heart failure NYHA III/IV, unstable angina pectoris) • Liver cirrhosis • ASA score \> III • Immunosuppressive therapy • Pregnancy or lactation • Understanding or language problems
  • Inability to comply with study and/or follow\-up procedures • Known allergy or intolerability to botulinum toxin • Any condition which could result in an undue risk for the patient in the opinion of the investigator

Investigators

Sponsor
niversitätsklinikum Heidelberg

Similar Trials